A detailed history of Schulhoff & CO Inc transactions in Pfizer Inc stock. As of the latest transaction made, Schulhoff & CO Inc holds 59,188 shares of PFE stock, worth $1.76 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
59,188
Previous 59,346 0.27%
Holding current value
$1.76 Million
Previous $1.65 Million 0.61%
% of portfolio
0.8%
Previous 0.77%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$25.26 - $29.6 $3,991 - $4,676
-158 Reduced 0.27%
59,188 $1.66 Million
Q1 2024

May 01, 2024

BUY
$25.89 - $29.73 $1,294 - $1,486
50 Added 0.08%
59,346 $1.65 Million
Q4 2023

Feb 07, 2024

BUY
$26.13 - $33.94 $68,904 - $89,499
2,637 Added 4.65%
59,296 $1.71 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $14,633 - $17,104
-456 Reduced 0.8%
56,659 $1.88 Million
Q2 2023

Aug 01, 2023

BUY
$36.12 - $41.79 $3,034 - $3,510
84 Added 0.15%
57,115 $2.09 Million
Q1 2023

May 05, 2023

BUY
$39.39 - $51.28 $1,221 - $1,589
31 Added 0.05%
57,031 $2.33 Million
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $107,715 - $140,610
-2,580 Reduced 4.33%
57,000 $2.92 Million
Q3 2022

Nov 08, 2022

BUY
$43.76 - $53.42 $1,006 - $1,228
23 Added 0.04%
59,580 $2.61 Million
Q2 2022

Aug 05, 2022

SELL
$46.53 - $55.17 $3,908 - $4,634
-84 Reduced 0.14%
59,557 $3.12 Million
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $5,993 - $7,426
-131 Reduced 0.22%
59,641 $3.09 Million
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $17,561 - $26,031
-425 Reduced 0.71%
59,772 $3.53 Million
Q3 2021

Nov 08, 2021

BUY
$39.25 - $50.42 $117 - $151
3 Added 0.0%
60,197 $2.59 Million
Q2 2021

Aug 03, 2021

BUY
$35.91 - $40.68 $6,751 - $7,647
188 Added 0.31%
60,194 $2.36 Million
Q1 2021

Apr 30, 2021

BUY
$33.49 - $37.77 $20,964 - $23,644
626 Added 1.05%
60,006 $2.17 Million
Q4 2020

Feb 08, 2021

SELL
$33.47 - $42.56 $4,250 - $5,405
-127 Reduced 0.21%
59,380 $2.19 Million
Q3 2020

Nov 04, 2020

BUY
$31.75 - $37.25 $23,431 - $27,490
738 Added 1.26%
59,507 $2.18 Million
Q2 2020

Jul 29, 2020

BUY
$30.12 - $36.54 $722 - $876
24 Added 0.04%
58,769 $1.92 Million
Q1 2020

Apr 30, 2020

BUY
$27.03 - $38.62 $16,353 - $23,365
605 Added 1.04%
58,745 $1.92 Million
Q4 2019

Jan 31, 2020

BUY
$32.92 - $37.36 $7,209 - $8,181
219 Added 0.38%
58,140 $2.28 Million
Q3 2019

Nov 01, 2019

SELL
$32.49 - $42.13 $59,521 - $77,182
-1,832 Reduced 3.07%
57,921 $2.08 Million
Q2 2019

Aug 07, 2019

BUY
$36.98 - $41.52 $22,742 - $25,534
615 Added 1.04%
59,753 $2.59 Million
Q1 2019

Apr 24, 2019

BUY
$37.5 - $41.2 $81,075 - $89,074
2,162 Added 3.79%
59,138 $2.51 Million
Q4 2018

Feb 07, 2019

SELL
$38.47 - $43.86 $11,002 - $12,543
-286 Reduced 0.5%
56,976 $2.49 Million
Q3 2018

Nov 07, 2018

BUY
$34.47 - $41.81 $34,987 - $42,437
1,015 Added 1.8%
57,262 $2.52 Million
Q2 2018

Aug 03, 2018

BUY
$32.98 - $35.16 $3,693 - $3,937
112 Added 0.2%
56,247 $2.04 Million
Q1 2018

Apr 26, 2018

SELL
$31.91 - $37.02 $9,030 - $10,476
-283 Reduced 0.5%
56,135 $1.99 Million
Q4 2017

Jan 26, 2018

BUY
$33.26 - $35.29 $3,858 - $4,093
116 Added 0.21%
56,418 $2.04 Million
Q3 2017

Oct 25, 2017

SELL
$31.0 - $34.15 $1,457 - $1,605
-47 Reduced 0.08%
56,302 $2.01 Million
Q2 2017

Aug 08, 2017

BUY
N/A
56,349
56,349 $1.89 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Schulhoff & CO Inc Portfolio

Follow Schulhoff & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schulhoff & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schulhoff & CO Inc with notifications on news.